Literature DB >> 30448457

The Future of Chimeric Antigen Receptor T Cell Therapy for the Treatment of Multiple Myeloma.

R Frank Cornell1, Luciano J Costa2.   

Abstract

Entities:  

Keywords:  BCMA; CAR T cell therapy; Cellular therapy; Gene therapy; Myeloma

Mesh：

Substances：

Year:  2018        PMID： 30448457     DOI： 10.1016/j.bbmt.2018.11.009

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  2 in total

1.  Long-Term Follow-up of CALGB (Alliance) 100001: Autologous Followed by Nonmyeloablative Allogeneic Transplant for Multiple Myeloma.

Authors:  Sarah A Holstein; Vera J Suman; Kouros Owzar; Katelyn Santo; Don M Benson; Thomas C Shea; Thomas Martin; Margarida Silverman; Luis Isola; Ravi Vij; Bruce D Cheson; Charles Linker; Kenneth C Anderson; Paul G Richardson; Philip L McCarthy
Journal:  Biol Blood Marrow Transplant       Date:  2020-04-20       Impact factor: 5.742

Review 2.  Summary of the Third Annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling.

Authors:  Sarah A Holstein; Zaid Al-Kadhimi; Luciano J Costa; Theresa Hahn; Parameswaran Hari; Jens Hillengass; Allison Jacob; Nikhil C Munshi; Stefania Oliva; Marcelo C Pasquini; Qian Shi; Edward A Stadtmauer; Stephanie L Waldvogel; Philip L McCarthy
Journal:  Biol Blood Marrow Transplant       Date:  2019-09-14       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.